Skip to main content

Table 3 The correlations between the overall survival and various clinicopathological factors

From: The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study

  Univariate analysis Multivariate analysis
Hazard ratio 95% CI p-value Hazard ratio 95% CI p-value
Age (≥65 vs. < 65 years) 1.266 0.869–1.845 0.219    
Gender (Female vs. Male) 1.300 0.895–1.888 0.169    
Performance status (≥1 vs. 0) 1.847 1.098–3.106 0.021 1.501 0.767–2.936 0.236
Location of primary tumor (Right side vs. Left side) 1.985 1.273–3.094 0.002 2.441 1.427–4.175 0.001
Histological type (Poorly, Mucinous vs. Well, Moderately) 0.710 0.368–1.370 0.307    
RAS status (Wild type vs. Mutant type) 1.697 1.095–2.628 0.018 1.416 0.902–2.222 0.131
Detection of unresectable tumor (Synchronous vs. Metachronous) 1.087 0.723–1.635 0.687    
Number of organs affected by metastasis (≥2 vs. 1) 1.142 0.770–1.693 0.509    
Peritoneal dissemination (Positive vs. Negative) 1.156 0.732–1.824 0.534    
Molecular-targeted therapy (Absent vs. Present) 1.148 0.783–1.684 0.480    
ALI (Low vs. High) 2.571 1.754–3.769 < 0.001 2.773 1.773–4.335 < 0.001
  1. CI Confidence interval, ALI Advanced lung cancer inflammation index